Literature DB >> 25632193

Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil.

José Miguel Luz Parente1, Claudio Saddy Rodrigues Coy1, Viriato Campelo1, Mírian Perpétua Palha Dias Parente1, Leonardo Araújo Costa1, Renata Mendes da Silva1, Celso Stephan1, José Murilo Robilotta Zeitune1.   

Abstract

AIM: To evaluate the demographic characteristics and clinical phenotypes of inflammatory bowel disease (IBD) in a geographic area in Northeastern Brazil.
METHODS: This retrospective study was conducted at the Hospital of the Federal University of Piauí in Northeastern Brazil. Demographic characteristics and clinical phenotypes of IBD were analyzed in relation to the time of diagnostic confirmation, which was defined as the date of disease onset. Data were collected between January 2011 and December 2012 and included all census patients 18 years of age or older during that period for whom there was diagnostic confirmation of Crohn's disease (CD), ulcerative colitis (UC), or unclassified colitis according to the Montreal criteria. We also analyzed the period of time between the onset of clinical manifestations and the diagnosis of IBD (delay in the diagnosis). Statistical analyses included means and standard deviations for numeric variables and the Pearson χ2 adherence test for nominal variables. The annual index occurrence and overall prevalence of IBD at our institution were also calculated, with P values<0.05 indicating statistical significance. This study was approved by the Institutional Ethics and Research Committee.
RESULTS: A total of 252 patients with IBD were included, including 152 (60.3%) UC patients and 100 (39.7%) CD patients. The clinical and demographic characteristics of all patients with IBD showed a female to male ratio of 1.3:1.0 and a mean age of 35.2 (SD=14.5) years. In addition, the majority of patients were miscegenated (171, 67.9%), had received higher education (157, 62.4%), lived in urban areas (217, 86.1%), and were under the age of 40 years (97, 62.5%). For patients with CD, according to the Montreal classification, the predominant features present from the onset of disease were an age between 17 and 40 years (A2); colonic disease location (L2); and nonstricturing, nonfistulizing disease behavior (B1). However, approximately one-quarter of all CD patients demonstrated perineal involvement. We also observed considerable delay in the diagnosis of IBD throughout the entire study period (mean=35.5 mo). In addition, the annual index occurrence rose from 0.08 to 1.53 cases/10(5) inhabitants/year during the study period, and the prevalence rate was 12.8 cases/10(5) inhabitants in 2012. Over the last two decades, there was a noted increase in the frequency of IBD in the study area.
CONCLUSION: In this study, there was a predominance of patients with UC, young people under 40 years of age, individuals with racial miscegenation, and low annual incomes.

Entities:  

Keywords:  Crohn’s disease; Epidemiology; Human Development Index; Inflammatory bowel diseases; Ulcerative colitis

Mesh:

Year:  2015        PMID: 25632193      PMCID: PMC4306164          DOI: 10.3748/wjg.v21.i4.1197

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.

Authors:  Laszlo Lakatos; Lajos S Kiss; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Peter Laszlo Lakatos
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

Review 2.  The effect of smoking on intestinal inflammation: what can be learned from animal models?

Authors:  Stephanie Verschuere; Rebecca De Smet; Liesbeth Allais; Claude A Cuvelier
Journal:  J Crohns Colitis       Date:  2011-10-12       Impact factor: 9.071

3.  Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy.

Authors:  Fabiana Castiglione; Maria Diaferia; Fabrizio Morace; Orazio Labianca; Costantino Meucci; Antonio Cuomo; Antonio Panarese; Marco Romano; Italo Sorrentini; Caterina D'Onofrio; Nicola Caporaso; Antonio Rispo
Journal:  J Crohns Colitis       Date:  2011-10-07       Impact factor: 9.071

Review 4.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

Review 5.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 6.  Crohn's disease.

Authors:  Daniel C Baumgart; William J Sandborn
Journal:  Lancet       Date:  2012-08-20       Impact factor: 79.321

Review 7.  Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Authors:  Eduard Cabré; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

Review 8.  Etiology of inflammatory bowel disease: a unified hypothesis.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

9.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 10.  Inflammatory bowel disease in Asia: a systematic review.

Authors:  Lani Prideaux; Michael A Kamm; Peter P De Cruz; Francis K L Chan; Siew C Ng
Journal:  J Gastroenterol Hepatol       Date:  2012-08       Impact factor: 4.029

View more
  32 in total

1.  Evaluation of Home Polysomnography Findings, Quality of Sleep, and Fatigue in Inflammatory Bowel Disease: A Case Series.

Authors:  Deise Lun Paixão; Dalva Poyares; Marta Sevilh de Paula; Joselmo Willamy Duarte; Paula Midor Castelo; Orlando Ambrogini-Júnior; Sender Jankie Miszputen; Celina Tizuko Fujiyam Oshima; Jair Ribeir Chagas; Ana Paula Ribeir Paiotti
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

Review 2.  Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.

Authors:  Danny J Avalos; Antonio Mendoza-Ladd; Marc J Zuckerman; Mohammad Bashashati; Andres Alvarado; Alok Dwivedi; Oriana M Damas
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

3.  Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.

Authors:  Kátia Simone Cezário de Barros; Cristina Flores; Luciana Harlacher; Carlos Fernando Magalhães Francesconi
Journal:  Dig Dis Sci       Date:  2017-07-26       Impact factor: 3.199

4.  Factors Predictive of Proximal Disease Extension and Clinical Course of Patients Initially Diagnosed with Ulcerative Proctitis in an IBD Referral Center.

Authors:  Sandro da Costa Ferreira; Lilian Rose Otoboni Aprile; Rogério Serafim Parra; Marley Ribeiro Feitosa; Gleici de Castro da Silva Perdoná; Omar Féres; José Joaquim Ribeiro da Rocha; Luiz Ernesto de Almeida Troncon
Journal:  Turk J Gastroenterol       Date:  2022-04       Impact factor: 1.555

Review 5.  Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.

Authors:  Tatiana Y Fofanova; Joseph F Petrosino; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-02       Impact factor: 2.839

6.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

Review 7.  Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.

Authors:  Jesús K Yamamoto-Furusho
Journal:  Pharmgenomics Pers Med       Date:  2017-05-26

8.  The prevalence and phenotype in Brazilian patients with inflammatory bowel disease.

Authors:  Adalberta Lima Martins; Rhaisa Almeida Volpato; Maria da Penha Zago-Gomes
Journal:  BMC Gastroenterol       Date:  2018-06-18       Impact factor: 3.067

Review 9.  A review of hematopoietic stem cell transplantation for autoimmune diseases: multiple sclerosis, systemic sclerosis and Crohn's disease. Position paper of the Brazilian Society of Bone Marrow Transplantation.

Authors:  Maria Carolina Oliveira; Juliana Bernardes Elias; Daniela Aparecida de Moraes; Belinda Pinto Simões; Morgani Rodrigues; Andreza Alice Feitosa Ribeiro; Lilian Piron-Ruiz; Milton Arthur Ruiz; Nelson Hamerschlak
Journal:  Hematol Transfus Cell Ther       Date:  2020-04-29

10.  Crohn's disease environmental factors in the developing world: A case-control study in a statewide catchment area in Brazil.

Authors:  Valéria Cristina Loureiro Salgado; Ronir Raggio Luiz; Neio Boechat; Bianca C Schorr; Isabella S Leão; Tiago Nunes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.